Evidence of a correlation of estrogen receptor level and avian osteoclast estrogen responsiveness

Journal of Bone and Mineral Research

Volumn 12, Issue 5, 1997, Pages 742-752

  Pederson, Larry ^a   Kremer, Matthew ^a   Foged, Niels Tækker ^b   Winding, Bent ^b   Ritchie, Candace ^a   Fitzpatrick, Lorraine A ^a   Oursler, Merry J ^c  

^a MAYO CLINIC   (United States)

^b CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^c UNIVERSITY OF MINNESOTA DULUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHICKEN; ENZYME RELEASE; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FOWL; GENE EXPRESSION; HORMONE RESPONSE; NEWBORN; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; OSTEOCLAST; OSTEOLYSIS; PREMENOPAUSE; PROTO ONCOGENE;

EID: 0030918877     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.5.742     Document Type: Article

References (37)

1. Parfitt AM 1979 Quantum concept of bone remodeling and turnover: Implications for the pathogenesis of osteoporosis. Calcif Tissue Int 28:1-5.
2. Eriksen E, Colvard D, Berg N, Graham M, Mann K, Spelsberg TC, Riggs BL 1988 Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-87.
3. Komm BS, Terpening C, Benz D, Graeme K, Gallegos A, Korc M 1988 Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241:81-84.
4. Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL and Spelsberg TC 1991 Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 88:6613-6617.
5. Oursler MJ, Pederson L, Fitzpatrick L, Riggs BL, Spelsberg TC 1994 Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci USA 91:5227-5231.
6. Oursler MJ, Pederson L, Pyfferoen J, Osdoby P, Fitzpatrick L and Spelsberg TC 1993 Estrogen modulation of avian osteoclast lysosomal gene expression. Endocrinology 132:1373-1380.
7. Kremer M, Judd J, Rifkin B, Auszmann J, Oursler MJ 1995 Estrogen modulation of osteoclast lysosomal enzyme secretion. J Cell Biochem 57:271-279.
8. Mano H, Yuasa T, Kameda T, Miyanzawa K, Nakamaru Y, Sjoplawa M, Mori Y, Yamada T, Miyata K, Shindo H, Azuma H, Hakeda Y, Kumegawa M 1996 Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun 223:637-642.
9. Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie RY, Manning CR, Jones C, Kurdyla JT, McNulty DE, Drake FH, Gowen M, Levy MA 1996 Proteolytic activity of human osteoclast cathepsin K. J Biol Chem 271:12517-12524.
10. Hoyland JA, Mee AP, Brown J, Braidman IP, Mawer EB, Freemont AJ 1996 Use of in situ-reverse transcriptase-polymerase cahin reaction to localize oestrogen receptor mRNA in bone. J Bone Miner Res 11:S221.
11. Jilka RL, Hangoc G, Girasole G, Passed G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91.
12. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Willians DC, Manolagas SC 1992 17β estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891.
13. Kassem M, Harris SA, Spelsber TC, Riggs BL 1996 Estrogen inhibits interleukin-6 production in a human osteoblastic cell line expressing high levels of estrogen receptors. J Bone Miner Res 11:193-199.
14. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N 1995 Modulation of osteoclast differentiation by local factors. Bone 17(Suppl):87S-91S.
15. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohusugi Y, Kumake K, Taga T, Kishimoto T, Suda T 1993 Soluable interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90:11924-11928.
16. Pacifici R, Rifas L, McCracken R, Vered I, McMurtry C, Avioli LV, Peck W 1989 Ovarian steroid treatment blocks a post-menopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398-2402.
17. Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio C, McCracken R, Avioli LV 1991 Effect of surgical menopause and estrogen replacement on cytokine release from human blood rnononuclear cells. Proc Natl Acad Sci USA 88:5134-5138.
18. Hannon RA, Blumsohn A, Galatti H, Fenner H, Russell RGG, Eastell R 1993 Cytokine receptors, receptor antagonists, and postmenopausal bone loss. J Bone Miner Res 8(Suppl 1):S152.
19. Kimble RB, Vannice JL, Bloedow DC, Thompson RC, Hopfer W, Rung V, Brownfield C, Pacifici R 1994 Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized mice. J Clin Invest 94:2397-2406.
20. Roodman GD 1992 Interleukine-6: An osteotropic factor? J Bone Miner Res 7:475-478.
21. Arnett TR, Lindsay R, Kilb JM, Moonga BS, Spowage M, Dempster DW, 1996 Selective toxic effects of tamoxifen on osteoclasts: Comparison with the effects of oestrogen. J Endocrinol 149:503-508.
22. +ATPase and bone resorption by tamoxifen and calmodulin antagonists. J Biol Chem 271:12488-12495.
23. Most W, Schot L, Ederveen A, van der Wee-Pals L, Papapoulos S, Lowik C 1995 In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis. J Bone Miner Res 10:1523-1530.
24. Collin-Osdoby P, Oursler MJ, Webber D, Osdoby P 1991 Osteoclast-specific monoclonal antibodies coupled to magnetic beads provide a rapid and efficient method for purifying avian osteoclasts. J Bone Miner Res 6:1353-1365.
25. Oursler MJ, Collin-Osdoby P, Anderson F, Li L, Webber D, Osdoby P 1991 Isolation of avian osteoclasts: Improved techniques to preferentially purify viable cells. J Bone Miner Res 6:375-385.
26. Foged NT, Delaisse J-M, Hou P, Lou H, Sato T, Winding B, Bonde M 1996 Quantification of the collagenolytic activity of isolated osteoclasts by enzyme-linked immunosorbent assay. J Bone Miner Res 11:226-237.
27. Chomczynske P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
28. Butler WB, Berlinski PJ, Hillman RM, Kelsey WH, Toenniges MM 1986 Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7. Cancer Res 46:6339-6348.
29. Yazidi IE, Boilly-Marer Y 1995 Production of acidic and basic fibroblast growth factor by the hormone-independent breast cancer cell line MDA-MB-231. Anticancer Res 15:783-790.
30. Barrett A, Kirschke H 1981 Proteases of diverse origin and function, cathepsin B, cathepsin D, cathepsin H, and cathepsin L. Meth Enzymol 80:535-561.
31. Hofstee BHJ 1954 Direct and continuous spectrophotometric assay of phosphomonoesterases. Arch Biochem Biophys 51:139-144.
32. Kanaro KJ, Furlow JD, Gorski J 1993 Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down regulation. Mol Endocrinol 7:879-888.
33. Lauber AH, Romao GJ, Mobbs CV, Pfaff DW 1990 Estradiol regulation of estrogen receptor messenger ribonucleic acid in rat mediobasal hypothalamus: An in situ hybridization study. J Neuroendocrinol 2:605-611.
34. Guiochon-Mantel A, Delabre K, Lescop P, Milgrom E 1996 Intracellular traffic of steroid hormone receptors J. Steroid Biochem Mol Biol 56:1-6.
35. Davis VL, Couse JF, Gray TK, Korach KS 1994 Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines. J Bone Miner Res 9:983-991.
36. Turner RT, Riggs BL, Spelsberg TC 1994 Skeletal effects of estrogen. Endocr Rev 15:275-300.
37. Braidman IP, Davenport LK, Carter DH, Selby PL, Mawer EB, Freemont AJ 1995 Preliminary in situ identification of estrogen target cells in bone. J Bone Miner Res 10:74-80.